Wakamoto Pharmaceutical Co., Ltd.(JP:4512)
Â¥286.00-1.00 (-0.35%)
JP:4512
Wakamoto Pharmaceutical Co., Ltd. Revenue
Â¥286.00
At close:-1.00 (-0.35%)
Want to see JP:4512 full AI Analyst Report?
Wakamoto Pharmaceutical Co., Ltd. (4512) Revenue
0 Followers
Wakamoto Pharmaceutical Co., Ltd. Revenue
Wakamoto Pharmaceutical Co., Ltd. had a revenue of 1.97B in the quarter ending Dec 31, 2023, with 11.94%. This bring the company's revenue in the last twelve months to 7.98B, Decreased 3.39%. In the fiscal year ending Mar 31, 2026, Wakamoto Pharmaceutical Co., Ltd. had annual revenue of 9.91B with 27.18% growth.
- Revenue (ttm)
- 7.98B
- Revenue Growth
- 23.41%
- P/S Ratio
- 1.01
- Revenue/Employee
- JPY 32,695,845
- Employees
- 303
- Market Cap
- JPY 9.96B
Revenue Chart
Wakamoto Pharmaceutical Co., Ltd. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 9.91B | 2.12B | 27.18% |
| Mar 31, 2025 | 7.79B | 51.04M | 0.66% |
| Mar 31, 2024 | 7.74B | -921.95M | -10.65% |
| Mar 31, 2023 | 8.66B | 277.23M | 3.31% |
| Mar 31, 2022 | 8.38B | -511.69M | -5.75% |
| Mar 31, 2021 | 8.89B | -2.02B | -18.53% |
| Mar 31, 2020 | 10.92B | 175.92M | 1.64% |
| Mar 31, 2019 | 10.74B | -158.90M | -1.46% |
| Mar 31, 2018 | 10.90B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.